302 related articles for article (PubMed ID: 32529807)
21. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
Oliveira LA; Almeida J; Benini R; Crestani CC
Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
[TBL] [Abstract][Full Text] [Related]
22. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
[TBL] [Abstract][Full Text] [Related]
24. Characterisation using microphysiometry of CRF receptor pharmacology.
Smart D; Coppell A; Rossant C; Hall M; McKnight AT
Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
[TBL] [Abstract][Full Text] [Related]
25. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
26. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
Sergio Tde O; Spiacci A; Zangrossi H
Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
[TBL] [Abstract][Full Text] [Related]
27. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
[TBL] [Abstract][Full Text] [Related]
28. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.
Dautzenberg FM; Gutknecht E; Van der Linden I; Olivares-Reyes JA; Dürrenberger F; Hauger RL
Biochem Pharmacol; 2004 Nov; 68(9):1833-44. PubMed ID: 15450949
[TBL] [Abstract][Full Text] [Related]
29. The effects of CRF and urocortins on the sociability of mice.
Bagosi Z; Karasz G; Czébely-Lénárt A; Csabafi K; Jászberényi M; Telegdy G
Brain Res; 2017 May; 1663():114-122. PubMed ID: 28315311
[TBL] [Abstract][Full Text] [Related]
30. Regulation of gonadotropins by urocortin 2 in gonadotropic tumor LβT2 cells.
Kageyama K; Murasawa S; Niioka K; Otsuka F; Yagi H; Daimon M
Neurosci Lett; 2017 Nov; 660():63-67. PubMed ID: 28851616
[TBL] [Abstract][Full Text] [Related]
31. Urocortin 3 expression at baseline and during inflammation in the colon: corticotropin releasing factor receptors cross-talk.
Mahajan S; Liao M; Barkan P; Takahashi K; Bhargava A
Peptides; 2014 Apr; 54():58-66. PubMed ID: 24462512
[TBL] [Abstract][Full Text] [Related]
32. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
Henry B; Vale W; Markou A
J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
[TBL] [Abstract][Full Text] [Related]
33. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission.
Liu J; Yu B; Neugebauer V; Grigoriadis DE; Rivier J; Vale WW; Shinnick-Gallagher P; Gallagher JP
J Neurosci; 2004 Apr; 24(16):4020-9. PubMed ID: 15102917
[TBL] [Abstract][Full Text] [Related]
34. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
McCarthy JR; Heinrichs SC; Grigoriadis DE
Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
[TBL] [Abstract][Full Text] [Related]
35. Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.
Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
Psychopharmacology (Berl); 2012 Apr; 220(3):599-610. PubMed ID: 21947356
[TBL] [Abstract][Full Text] [Related]
36. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
Verleye M; André N; Gillardin JM
Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
[TBL] [Abstract][Full Text] [Related]
38. The CRF peptide family and their receptors: yet more partners discovered.
Dautzenberg FM; Hauger RL
Trends Pharmacol Sci; 2002 Feb; 23(2):71-7. PubMed ID: 11830263
[TBL] [Abstract][Full Text] [Related]
39. Don't stress about CRF: assessing the translational failures of CRF
Spierling SR; Zorrilla EP
Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
[TBL] [Abstract][Full Text] [Related]
40. Effects of stress-related peptides on chloride secretion in the mouse proximal colon.
Liu S; Karo A; Agterberg S; Hua H; Bhargava A
Neurogastroenterol Motil; 2021 Apr; 33(4):e14021. PubMed ID: 33118282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]